eMedicine Specialties > Ophthalmology > Infectious Disease

Ocular Manifestations of Syphilis: Differential Diagnoses & Workup

Author: Manolette R Roque, MD, MBA, DPBO, FPAO, President and CEO, Chief of Service, Ocular Immunology and Uveitis, Consulting Staff, Cornea and Refractive Surgery, Eye Republic Ophthalmology Clinic; General Manager, Ophthalmic Consultants Philippines Co; Consulting Staff, CME Liaison, Section Chief of Ocular Immunology and Uveitis, Department of Ophthalmology, Asian Hospital and Medical Center
Coauthor(s): Barbara L Roque, MD, Full Partner, Ophthalmic Consultants Philippines Co, Chief of Service, Pediatric Ophthalmology and Strabismus, Consulting Staff, Orbit and Eye Plastics, EYE REPUBLIC Ophthalmology Clinic; C Stephen Foster, MD, FACS, FACR, FAAO, Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Founder and President, Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institute
Contributor Information and Disclosures

Updated: Dec 26, 2007

Differential Diagnoses

Acute Multifocal Placoid Pigment Epitheliopathy
Scleritis
Episcleritis
Stevens-Johnson Syndrome
HIV
Tuberculosis
Keratitis, Interstitial
Uveitis, Anterior, Granulomatous
Ocular Manifestations of HIV
Uveitis, Classification
Papilledema
Uveitis, Evaluation and Treatment
Psoriasis
Retinal Detachment, Exudative
Sarcoidosis

Other Problems to Be Considered

Iritis
Chorioretinitis
Retinal vasculitis
Papillitis
Iris papules
Neurosyphilis
Genital warts
Condyloma acuminata
Lymphogranuloma venereum
Chancroid
Traumatic superinfected lesions
Carcinoma
Mycotic infection
Granuloma inguinale
Lichen planus
Fungal infection
Venereal chlamydial infections
Drug eruptions
Pityriasis rosea
Viral exanthem

Workup

Laboratory Studies

  • Serologic nontreponemal tests include Venereal Disease Research Laboratory (VDRL) and rapid plasma reagin (RPR).
    • Nontreponemal tests detect antibodies directed against cardiolipin (lecithin) cholesterol antigens.
    • It is simple and convenient for routine screening at the local level. It is a frequent local requirement for premarital and prenatal serology. The false-positive rate for pregnant women is 1-2%.
    • A minimum of 1-3 weeks must pass from the onset of infection for the test to turn positive. It usually is positive in primary syphilis and invariably positive in secondary syphilis.
    • A high titer (>1:16) usually indicates active disease. Biologic false-positive tests (usually <1:8) occur in intravenous drug users, in many acute infections (eg, infectious mononucleosis, mycoplasmal infection, malaria, leprosy), in a variety of chronic disorders (eg, systemic lupus erythematosus), and possibly pregnancy.
    • Quantification of VDRL always should be performed before onset of treatment.
    • Nontreponemal test titers should decrease by 4-fold within 3 months of adequate treatment of primary or secondary disease, and they should decrease by 8-fold within 6 months following therapy for early latent disease.
    • The cerebrospinal fluid (CSF) titer also should diminish with adequate therapy for neurosyphilis; however, the serum nontreponemal test titer may not change in patients with late latent syphilis.
    • The VDRL titer reflects the systemic activity of the disease. Its major value is in monitoring the response to treatment.
    • A persistent fall in VDRL titers after treatment provides essential evidence of an adequate response to therapy.
    • Reactive and weakly reactive tests should be confirmed with fluorescent treponemal antibody absorption (FTA-ABS).
  • Serologic treponemal tests include micro-hemagglutination T pallidum (MHA-TP), FTA-ABS, T pallidum particle agglutination (TPA).
    • Their greatest value is in distinguishing false-positive from true-positive reagin test results and in diagnosing late syphilis when blood and CSF reagin test results may be negative.
    • These are highly sensitive and specific tests.
    • Titers are not correlated with clinical activity.
    • The FTA-ABS test is not useful in monitoring response to therapy because it typically remains positive for life.
    • The FTA-ABS test is 98% sensitive, even in latent syphilis.
    • FTA-ABS test and TPA test are preferred over MHA-TP.

Other Tests

  • Dark-field immunofluorescence microscopy (direct technique)
    • Fluorescein-labeled anti-T pallidum antibodies are used in an immunofluorescence analysis of exudate or samples are taken from a lesion suggestive of syphilis.
    • The antibody attaches to syphilitic organisms displaying a motile apple-green, corkscrew-shaped T pallidum.
  • Electron microscopy: T pallidum organisms can be seen in interstitial and perivascular spaces.
  • Ganzfeld electroretinogram (ERG)
    • Ganzfeld ERG was markedly reduced in a case of acute syphilitic posterior placoid chorioretinitis.
    • Multifocal ERG in the affected area was not recordable.
  • Indocyanine green (ICG) angiography
    • ICG angiography may be a valuable tool in the assessment of patients with active ocular syphilis.
    • ICG angiography can help identify retinal and choroidal vascular anomalies that would otherwise go undetected by funduscopy and/or fluorescein angiography.
    • ICG angiography can also be useful in monitoring antitreponemal therapy.
    • The following 2 types of anomalies were observed:
      • Late-phase scattered hyperfluorescent spots
      • Persistent staining of retinal vessels

Procedures

  • Lumbar puncture
    • Evaluation for asymptomatic neurosyphilis
    • Patients with positive syphilitic serologic tests should have their CSF examined for VDRL titers, total protein, and cell counts, including a differential count.
    • An elevated WBC count with a predominance of lymphocytes in the CSF or an elevated total protein level, even without a positive CSF VDRL test, is indicative of neurologic involvement, and the patient should be treated accordingly, as for neurosyphilis.
  • HIV evaluation
    • Patients with ocular syphilis should be evaluated for HIV and vice versa.
    • Reports indicate that young adult patients who are HIV positive often have ocular syphilis.
    • Patients who have HIV may experience an aggressive course of syphilis, rendering standard therapy for primary and secondary syphilis inadequate.
  • Polymerase chain reaction
    • Diagnostic role in unusual or atypical ocular inflammation
    • Aqueous or vitreous specimens

Histologic Findings

The organisms usually are superficial in epithelial lesions. A diffuse or focal lymphocytic infiltration is characteristic, particularly perivascularly. The tissue reaction is notable for stenosing intimal fibroplasia of small arteries and arterioles (eg, onion-skinning, obliterative endarteritis), as well as perivascular plasma infiltrate with some lymphocytes and macrophages. It may be found in the iris, ciliary body, or choroid. Chronic granulomatous inflammation containing epithelioid histiocytes and multinucleated giant cells is present. Overlying epidermal changes in skin can be hyperplastic (eg, condylomata lata) or ulcerating (eg, chancre). In tertiary disease, gummas are present (ie, areas of coagulative necrosis surrounded by lymphocytes, plasma cells, and possibly giant cells), and organisms are more abundant. Warthin-Starry silver stain, a specialized direct staining technique, sometimes is used.

More on Ocular Manifestations of Syphilis

Overview: Ocular Manifestations of Syphilis
Differential Diagnoses & Workup: Ocular Manifestations of Syphilis
Treatment & Medication: Ocular Manifestations of Syphilis
Follow-up: Ocular Manifestations of Syphilis
Multimedia: Ocular Manifestations of Syphilis
References

References

  1. Garfinkel M, Blumstein H. Gender differences in testing for syphilis in emergency department patients diagnosed with sexually transmitted diseases. J Emerg Med. Nov-Dec 1999;17(6):937-40. [Medline].

  2. Aldave AJ, King JA, Cunningham ET Jr. Ocular syphilis. Curr Opin Ophthalmol. Dec 2001;12(6):433-41. [Medline].

  3. Baglivo E, Kapetanios A, Safran AB. Fluorescein and indocyanine green angiographic features in acute syphilitic macular placoid chorioretinitis. Can J Ophthalmol. Aug 2003;38(5):401-5. [Medline].

  4. Browning DJ. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology. Nov 2000;107(11):2015-23. [Medline].

  5. Deschenes J, Seamone CD, Baines MG. Acquired ocular syphilis: diagnosis and treatment. Ann Ophthalmol. Apr 1992;24(4):134-8. [Medline].

  6. Diaz-Valle D, Allen DP, Sanchez AA, Aguado CB, Benitez Del Castillo JM, Acenero MJ. Simultaneous bilateral exudative retinal detachment and peripheral necrotizing retinitis as presenting manifestations of concurrent HIV and syphilis infection. Ocul Immunol Inflamm. Dec 2005;13(6):459-62. [Medline].

  7. Dinis da Gama R, Cidade M. Images in clinical medicine. Interstitial keratitis as the initial expression of syphilitic reactivation. N Engl J Med. Jun 6 2002;346(23):1799. [Medline].

  8. Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: the new epidemic. Eye. Jun 2006;20(6):703-5. [Medline].

  9. Durnian JM, Naylor G, Saeed AM. Ocular syphilis: the return of an old acquaintance. Eye. Apr 2004;18(4):440-2. [Medline].

  10. Edmonds LC, Stubbs SE, Ryu JH. Syphilis: a disease to exclude in diagnosing sarcoidosis. Mayo Clin Proc. Jan 1992;67(1):37-41. [Medline].

  11. Fathilah J, Choo MM. The Jarisch-Herxheimer reaction in ocular syphilis. Med J Malaysia. Aug 2003;58(3):437-9. [Medline].

  12. Goegebuer A, Ajay L, Claerhout I, Kestelyn P. Results of penetrating keratoplasty in syphilitic interstitial keratitis. Bull Soc Belge Ophtalmol. 2003;(290):35-9. [Medline].

  13. Halperin LS, Lewis H, Blumenkranz MS, Gass JD, Olk RJ, Fine SL. Choroidal neovascular membrane and other chorioretinal complications of acquired syphilis. Am J Ophthalmol. Nov 15 1989;108(5):554-62. [Medline].

  14. Hariprasad SM, Moon SJ, Allen RC, Wilhelmus KR. Keratopathy from congenital syphilis. Cornea. Aug 2002;21(6):608-9. [Medline].

  15. Kawaguchi R, Saika S, Wakayama M, Ooshima A, Ohnishi Y, Yabe H. Extracellular matrix components in a case of retrocorneal membrane associated with syphilitic interstitial keratitis. Cornea. Jan 2001;20(1):100-3. [Medline].

  16. Kiss S, Damico FM, Young LH. Ocular manifestations and treatment of syphilis. Semin Ophthalmol. Jul-Sep 2005;20(3):161-7. [Medline].

  17. Margo CE, Hamed LM. Ocular syphilis. Surv Ophthalmol. Nov-Dec 1992;37(3):203-20. [Medline].

  18. Matsuo T, Taira Y, Nagayama M, Baba T. Angle-closure glaucoma as a presumed presenting sign in patients with syphilis. Jpn J Ophthalmol. May-Jun 2000;44(3):305-8. [Medline].

  19. McCall MB, van Lith-Verhoeven JJ, van Crevel R, Crama N, Koopmans PP, Hoyng CB, et al. Ocular syphilis acquired through oral sex in two HIV-infected patients. Neth J Med. Jun 2004;62(6):206-8. [Medline].

  20. Menon SR, Fleischhauer J, Jost K, Helbig H. Clinical and electrophysiological course of acute syphilitic posterior placoid chorioretinitis. Klin Monatsbl Augenheilkd. Mar 2005;222(3):261-3. [Medline].

  21. Moloney G, Branley M, Kotsiou G, Rhodes D. Syphilis presenting as scleritis in an HIV-positive man undergoing immune reconstitution. Clin Experiment Ophthalmol. Oct 2004;32(5):526-8. [Medline].

  22. Mora P, Borruat FX, Guex-Crosier Y. Indocyanine green angiography anomalies in ocular syphilis. Retina. Feb-Mar 2005;25(2):171-81. [Medline].

  23. Morgan CM, Webb RM, O'Connor GR. Atypical syphilitic chorioretinitis and vasculitis. Retina. Fall-Winter 1984;4(4):225-31. [Medline].

  24. Ormerod LD, Puklin JE, Sobel JD. Syphilitic posterior uveitis: correlative findings and significance. Clin Infect Dis. Jun 15 2001;32(12):1661-73. [Medline].

  25. Orsoni JG, Zavota L, Manzotti F. Syphilitic interstitial keratitis: treatment with immunosuppressive drug combination therapy. Cornea. Jul 2004;23(5):530-2. [Medline].

  26. Pao D, Goh BT, Bingham JS. Management issues in syphilis. Drugs. 2002;62(10):1447-61. [Medline].

  27. Passo MS, Rosenbaum JT. Ocular syphilis in patients with human immunodeficiency virus infection. Am J Ophthalmol. Jul 15 1988;106(1):1-6. [Medline].

  28. Peters GB 3rd, Krohel GB. Active ocular syphilis. Ophthalmology. Sep 2001;108(9):1515-6. [Medline].

  29. Physicians' Desk Reference. 53rd ed. Montvale, NJ: Thomson Healthcare; 1999.

  30. Rodriguez-Diaz E, Moran-Estefania M, Lopez-Avila A, Piris JB, Fernandez-Blasco G, Garcia JI, et al. Clinical expression of secondary syphilis in a patient with HIV infection. J Dermatol. Feb 1994;21(2):111-6. [Medline].

  31. Sakai T, Shikishima K, Mizobuchi T, Yoshida M, Kitahara K. Bilateral tonic pupils associated with neurosyphilis. Jpn J Ophthalmol. Jul-Aug 2003;47(4):368-71. [Medline].

  32. Schurmann D, Bergmann F, Bertelmann E, Padberg J, Liekfeld A, Pleyer U. Early diagnosis of acquired ocular syphilis requires a high index of suspicion and may prevent visual loss. AIDS. Apr 1 1999;13(5):623-4. [Medline].

  33. Spoor TC, Wynn P, Hartel WC, Bryan CS. Ocular syphilis. Acute and chronic. J Clin Neuroophthalmol. Sep 1983;3(3):197-203. [Medline].

  34. Tabbara KF, al Kaff AS, Fadel T. Ocular manifestations of endemic syphilis (bejel). Ophthalmology. Jul 1989;96(7):1087-91. [Medline].

  35. Tamesis RR, Foster CS. Ocular syphilis. Ophthalmology. Oct 1990;97(10):1281-7. [Medline].

  36. Thami GP, Kaur S, Gupta R, Kanwar AJ, Sood S. Syphilitic panuveitis and asymptomatic neurosyphilis: a marker of HIV infection. Int J STD AIDS. Nov 2001;12(11):754-6. [Medline].

  37. Tran TH, Cassoux N, Bodaghi B. Syphilitic uveitis in patients infected with human immunodeficiency virus. Graefes Arch Clin Exp Ophthalmol. Sep 2005;243(9):863-9. [Medline].

  38. Williams JK, Kirsch LS, Russack V, Freeman WR. Rhegmatogenous retinal detachments in HIV-positive patients with ocular syphilis. Ophthalmic Surg Lasers. Aug 1996;27(8):699-705. [Medline].

  39. Yokoi M, Kase M. Retinal vasculitis due to secondary syphilis. Jpn J Ophthalmol. Jan-Feb 2004;48(1):65-7. [Medline].

Further Reading

Keywords

ocular syphilis, interstitial keratitis, episcleritis, scleritis, iritis, iris papules, chorioretinitis, papillitis, retinal vasculitis, exudative retinal detachment, primary syphilis, secondary syphilis, latent syphilis, tertiary syphilis, quaternary syphilis, Treponema pallidum, T pallidum, lues, chancre, gumma, sexually transmitted disease, STD, HIV, AIDS

Contributor Information and Disclosures

Author

Manolette R Roque, MD, MBA, DPBO, FPAO, President and CEO, Chief of Service, Ocular Immunology and Uveitis, Consulting Staff, Cornea and Refractive Surgery, Eye Republic Ophthalmology Clinic; General Manager, Ophthalmic Consultants Philippines Co; Consulting Staff, CME Liaison, Section Chief of Ocular Immunology and Uveitis, Department of Ophthalmology, Asian Hospital and Medical Center
Manolette R Roque, MD, MBA, DPBO, FPAO is a member of the following medical societies: American Academy of Ophthalmic Executives, American Society of Cataract and Refractive Surgery, American Society of Ophthalmic Administrators, American Uveitis Society, International Ocular Inflammation Society, Philippine Medical Association, Philippine Ocular Inflammation Society, and Philippine Society of Cataract and Refractive Surgery
Disclosure: Nothing to disclose.

Coauthor(s)

Barbara L Roque, MD, Full Partner, Ophthalmic Consultants Philippines Co, Chief of Service, Pediatric Ophthalmology and Strabismus, Consulting Staff, Orbit and Eye Plastics, EYE REPUBLIC Ophthalmology Clinic
Disclosure: Nothing to disclose.

C Stephen Foster, MD, FACS, FACR, FAAO, Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary; Founder and President, Ocular Immunology and Uveitis Foundation, Massachusetts Eye Research and Surgery Institute
C Stephen Foster, MD, FACS, FACR, FAAO is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Association of Immunologists, American College of Rheumatology, American College of Surgeons, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, American Uveitis Society, Association for Research in Vision and Ophthalmology, Massachusetts Medical Society, Royal Society of Medicine, Sigma Xi, and Washington State Medical Association
Disclosure: Nothing to disclose.

Medical Editor

John D Sheppard, Jr, MD, MMSc, Associate Professor of Ophthalmology, Microbiology and Immunology, Director for Thomas R Lee Center for Ocular Pharmacology, Director, Uveitis Service, Eastern Virginia School of Medicine; Consulting Staff, Virginia Eye Consultants
John D Sheppard, Jr, MD, MMSc is a member of the following medical societies: American Academy of Ophthalmology, American Society for Microbiology, American Uveitis Society, Association for Research in Vision and Ophthalmology, and Contact Lens Association of Ophthalmologists
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

J James Rowsey, MD, Director of Corneal Services, St Luke's Cataract and Laser Institute, Florida
Disclosure: Nothing to disclose.

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.